Ladenburg Thalmann Financial Services’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3K	Buy	1,100 +100	+10%	+$318	﹤0.01%	5027
2019 Q3	$3K	Sell	1,000 -500	-33%	-$1.41K	﹤0.01%	4918
2019 Q2	$4K	Hold	1,500	–	–	﹤0.01%	4830
2019 Q1	$6K	Hold	1,500	–	–	﹤0.01%	4616
2018 Q4	$5K	Hold	1,500	–	–	﹤0.01%	4642
2018 Q3	$9K	Buy	1,500 +500	+50%	+$2.86K	﹤0.01%	4363
2018 Q2	$5K	Hold	1,000	–	–	﹤0.01%	4625
2018 Q1	$5K	Hold	1,000	–	–	﹤0.01%	4625
2017 Q4	$6K	Sell	1,000 -21,000	-95%	-$126K	﹤0.01%	4479
2017 Q3	$122K	Sell	22,000 -1,000	-4%	-$5.17K	﹤0.01%	2473
2017 Q2	$107K	Buy	23,000 +22,000	+2,200%	+$98.2K	﹤0.01%	2475
2017 Q1	$5K	Hold	1,000	–	–	﹤0.01%	4340
2016 Q4	$11K	Hold	1,000	–	–	﹤0.01%	3856
2016 Q3	$9K	Hold	1,000	–	–	﹤0.01%	3908
2016 Q2	$6K	Hold	1,000	–	–	﹤0.01%	4073
2016 Q1	$7K	Hold	1,000	–	–	﹤0.01%	3928
2015 Q4	$8K	Sell	1,000 -500	-33%	-$3.74K	﹤0.01%	3835
2015 Q3	$11K	Buy	1,500 +750	+100%	+$7.64K	﹤0.01%	3490
2015 Q2	$8K	Buy	750 +250	+50%	+$2.76K	﹤0.01%	3846
2015 Q1	$5K	Hold	500	–	–	﹤0.01%	4011
2014 Q4	$4K	Buy	+500	New	+$2.86K	﹤0.01%	3855

Other funds holding FOMX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FOMX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) stake by 10% in Q4 2019, buying an estimated $318 and bringing the position to 1,100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #5027.

Ladenburg Thalmann Financial Services first reported a position in FOMX in Q4 2014 and has held it in 21 quarters since. The position peaked at $122K in Q3 2017. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

Ladenburg Thalmann Financial Services held 1,100 shares of Foamix Pharmaceuticals Ltd. Ordinary Shares worth $3K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 100 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2019, an estimated $318.
Foamix Pharmaceuticals Ltd. Ordinary Shares made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5027 holding.
Ladenburg Thalmann Financial Services first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2014 and has held it in 21 quarters since.
Ladenburg Thalmann Financial Services's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $122K in Q3 2017.
65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.